Harald Casebourne Stock

Harald Casebourne Stock has a diverse work experience spanning various companies and roles. Harald is currently the Co-Founder and Non-Executive Director at Cered, Inc. since September 2022. Prior to that, they were the Co-Founder and Executive Chair at Domus Diagnostics, Inc. starting from April 2021. Harald also co-founded and served as the Executive Chair at Eptiva Therapeutics Ltd. from October 2020.

In terms of their involvement in the healthcare industry, Harald has extensive experience as a Co-Founder and Non-Executive Director at CognifiSense, Inc., a company focused on developing digital prescription therapeutics for neurological conditions. Harald held these roles from December 2015 to April 2022. Harald was also a Non-Executive Director at Rentschler Biopharma SE, a global Contract Development and Manufacturing Organization, starting from May 2021.

Additionally, Harald served as a Non-Executive Director at Consilient Health, a pharmaceutical company, starting from October 2018. Harald was also the Executive Chair at Blue Therapeutics, an early-stage biotechnology company, from November 2019 to December 2020 and again from August 2022 to December 2022.

Harald has been involved in the strategic advisory roles at Quantum Diamond Technologies Inc (QDTI), a quantum sensor capability company, from April 2017 to November 2017, and then from February 2021 to March 2021. Harald also served as a Non-Executive Director at QDTI from November 2017 to February 2021.

Furthermore, Harald has experience as a Non-Executive Director at Immatics Biotechnologies from January 2011 to July 2020, and at OvaScience, where they also held the roles of President & Chief Executive Officer from July 2016 to December 2016, and CEO-elect from January 2016 to June 2016.

Overall, Harald Casebourne Stock has demonstrated their expertise and leadership in various positions within the biotechnology and pharmaceutical industries.

Harald Casebourne Stock completed their Vordiplom in Chemistry from Technische Universität Braunschweig, Germany, where they studied from 1987 to 1989. Harald then pursued further education at Heidelberg University, Germany, and obtained their Doctor of Philosophy (Ph.D.) in Inorganic Chemistry from 1989 to 1996. Additionally, in 1990 to 1991, they received an ERASMUS Grant and enrolled at the University of Bristol, United Kingdom, to study Chemistry.